AusCann Group Holdings (ASX:AC8) Managing Director, Elaine Darby presents its final dose cannabinoid capsule study, 2018 crop yields, production and outlook.
- Delivering high quality, cost effective cannabinoid medicines to patients
- Pharmaceutical products for the management of chronic pain
- Regulatory update - two key Federal Government changes
- Processes to provide patients with access
- Opening up of export opportunity
- Joint venture based in Chile between AC8 and Fundación Daya
For more information, watch Managing Director Elaine Darby present.